Effect of diphenylhydantoin on hepatic drug hydroxylation.
D000328:Adult; D000983:Antipyrine; D001663:Bilirubin / Q000097:blood; D003124:Colorimetry; D003404:Creatinine / Q000378:metabolism; D004827:Epilepsy / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D006900:Hydroxylation; D007565:Jaundice / Q000188:drug therapy; D008099:Liver / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010624:Phenelzine / Q000378:metabolism; D010672:Phenytoin / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use
D004364:Pharmaceutical Preparations; D010672:Phenytoin; D003404:Creatinine; D010624:Phenelzine; D001663:Bilirubin; D000983:Antipyrine